TDF is a cost effective alternative in chronic hepatitis B infection Clinical study 13 February 2013 Pages: 1 - 1
The National Comprehensive Cancer Network (NCCN) has announced important updates Media release 13 February 2013 Pages: 2 - 2
Guidelines for OA of the hip and knee: has the evidence changed? Clinical study 13 February 2013 Pages: 3 - 3
Initial infliximab valuable, but not initially, for RA in the UK Clinical study 13 February 2013 Pages: 5 - 5
Addition of cetuximab to radiotherapy good value for money Clinical study 13 February 2013 Pages: 5 - 5
Economics for endoscopic procedures “not financially viable” Clinical study 13 February 2013 Pages: 7 - 7
Chronic medication use on the rise in the younger population Media release 13 February 2013 Pages: 7 - 7
It pays to pick beclometasone/formoterol for asthma in Spain Meeting report 13 February 2013 Pages: 9 - 9
Natalizumab reduces hospitalisation rate in patients with CD Clinical study 13 February 2013 Pages: 9 - 9
Free drug samples not going to most needy children in the US Clinical study 13 February 2013 Pages: 9 - 9
Rising costs of cancer care influencing therapy options Media release 13 February 2013 Pages: 13 - 13
Global pharma market set to soar in 2009 while US growth levels off Media release 13 February 2013 Pages: 14 - 14
German PAH patients to need two doctors' consent for costly drugs News item 13 February 2013 Pages: 15 - 15